Physician

Prasad R Kudalkar, MD

According to 2025 Medicare claims, Prasad Kudalkar, MD (NPI: 1013094382) practices hematology/oncology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Butler, OH. This provider's primary affiliated billing organization is ONCOLOGY HEMATOLOGY CARE INC (NPI: 1790778041; TIN: 311106418) and primary practice location at 45014-5376. Kudalkar is affiliated with the Mercy Health Select, LLC (ACO ID: A1215), participating under the MSSP model.

Kudalkar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 604 traditional Medicare patients, billed 105,549 HCPCS/CPT codes, and received $2,106,420 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,707 prescription claims across 403 beneficiaries totaling $3,699,157 in drug costs, led by Imbruvica (Ibrutinib). 2023 DME data shows 33 claims. Open Payments data shows 36 records totaling $706. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $1,856,433 to $3,699,157. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $5,804 and ending at $1,252.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	682	113,823	$1,658,105
2016	712	107,170	$1,527,552
2017	764	113,731	$1,738,296
2018	842	123,695	$2,082,413
2019	759	149,838	$2,826,291
2020	629	130,546	$2,533,511
2021	699	162,034	$2,853,235
2022	602	134,468	$2,726,431
2023	648	114,549	$2,324,244
2024	604	105,549	$2,106,420

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	294	2,708	$1,856,433
2016	284	2,534	$2,078,252
2017	321	2,785	$2,150,039
2018	322	2,516	$2,042,308
2019	352	2,444	$2,573,046
2020	365	2,844	$2,264,030
2021	384	2,826	$2,467,317
2022	383	2,697	$3,165,523
2023	400	2,636	$3,434,693
2024	403	2,707	$3,699,157

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	24	$1,940
2016	N/R	23	$1,418
2017	N/R	219	$97,078
2018	N/R	203	$95,269
2019	N/R	123	$89,237
2020	N/R	81	$136,127
2021	N/R	174	$181,494
2022	N/R	67	$161,546
2023	N/R	33	$1,354
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	160	318	$86
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	338	618	$59
82728	Ferritin (blood protein) level	92	131	$13
80053	Blood test, comprehensive group of blood chemicals	273	659	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	312	912	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	33	924	$518,535
Ibrance	Palbociclib	25	700	$384,829
Alecensa	Alectinib Hcl	17	540	$311,843
Cabometyx	Cabozantinib S-Malate	11	330	$286,997
Lenvima	Lenvatinib Mesylate	12	360	$276,707

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	36	$706	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Prasad R. Kudalkar, MD?

Tedicare shows public-source Medicare data for Prasad R. Kudalkar, MD (NPI 1013094382), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Prasad R. Kudalkar, MD have ACO affiliation data?

Prasad R. Kudalkar, MD is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215).

What billing organization is linked to Prasad R. Kudalkar, MD?

Prasad R. Kudalkar, MD is linked to ONCOLOGY HEMATOLOGY CARE INC (billing NPI 1790778041) in the available physician profile data.

Does Prasad R. Kudalkar, MD have Open Payments data?

Prasad R. Kudalkar, MD has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.